Nasdaq

Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications

LONDON, Jan. 27, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce a new publication showing that its PICO Single Use Negative ...
Nasdaq

Smith+Nephew's PICO™ 7 and PICO 14 Negative Pressure Wound Therapy Systems are the first systems indicated to aid in reducing the incidence of both deep and superficial ...

Superficial and deep incisional surgical site infections (SSIs) for high risk patients in Class I and Class II wounds Post-operative seroma Dehiscence The development of post-operative surgical site ...
Business Wire

Aatru Medical Announces Clinical Study and Interim Analysis of Their NPSIMS™ - Negative Pressure Surgical Incision Management System

CLEVELAND--(BUSINESS WIRE)--Aatru Medical, LLC ("Aatru") today announced the successful completion of the first 14 patients in their multi-center New Zealand-based clinical study of the FDA-approved ...
Monthly Prescribing Reference

FDA Clears PICO Systems for Closed Surgical Incisions to Reduce Wound Complications

The clearance was based on data from 25 clinical studies which included 5560 patients. The Food and Drug Administration (FDA) has cleared Smith+Nephew’s PICO 7 and PICO 14 Single Use Negative Pressure ...